Real-time enrollment status for this gram-negative infection clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:01 PM UTC
| NCT Number | NCT06709521 |
| Recruiting Status | Recruiting |
| Condition | Gram-negative infection |
| Phase | PHASE4 |
| Target Enrollment | 200 participants |
| Active Locations | 10 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06709521 is currently recruiting participants. This phase4 study for gram-negative infection is actively seeking new participants at 10 locations across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06709521 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06709521 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.